Cargando…
Preclinical Evidences for an Antimanic Effect of Carvedilol
Oxidative imbalance, alterations in brain-derived neurotrophic factor (BDNF), and mitochondrial dysfunction are implicated in bipolar disorder (BD) pathophysiology and comorbidities, for example, cardiovascular conditions. Carvedilol (CVD), a nonselective beta-blocker widely used for the treatment o...
Autores principales: | de Souza, Greicy Coelho, Gomes, Julia Ariana de S., de Góis Queiroz, Ana Isabelle, de Araújo, Maíra Morais, Cavalcante, Lígia Menezes, Machado, Michel de Jesus Souza, Monte, Aline Santos, de Lucena, David Freitas, Quevedo, João, Carvalho, André Ferrer, Macêdo, Danielle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446493/ https://www.ncbi.nlm.nih.gov/pubmed/26075103 http://dx.doi.org/10.1155/2015/692541 |
Ejemplares similares
-
Effect of the Dysbindin Gene on Antimanic Agents in Patients with Bipolar I Disorder
por: Yun, Dong-Hwan, et al.
Publicado: (2008) -
Can Antipsychotic Agents be Considered as Real Antimanic Treatments?
por: Bourin, Michel, et al.
Publicado: (2014) -
Audit of Antimanic Agents Monitoring in a High Secure Hospital
por: Oluwaranti, Oluwaseun, et al.
Publicado: (2023) -
Carvedilol Decrease IL-1β and TNF-α, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of Periodontitis
por: de Araújo Júnior, Raimundo Fernandes, et al.
Publicado: (2013) -
Electroanalysis Applied to Compatibility and Stability Assays of Drugs: Carvedilol Study Case
por: de Carvalho, Murilo Ferreira, et al.
Publicado: (2020)